The Aurum Institute needed to integrate clinical data from cross-border research sites located in several sub-Saharan African countries, each run by data managers who speak different languages and possess varied levels of experience with electronic data capture.
Personal values. Commercial pressures. These are forces that shape our jobs every day, especially for leaders in the life sciences. As individuals, we want to solve urgent problems that touch us deeply. As professionals representing growing businesses, we act on our beliefs best when they align with distinct market opportunities. The oft heard slogan of […]
I have worked with various flavors of Watson in the last 4 years, and it has taught me a lot about the need to understand bias, both in data and the interpretation of it. In the spirit of transparency, I will be honest about my own bias – my favorite Watson Health product is Watson […]
SmartAnalyst and the IBM® Watson Health™ team used the IBM Explorys® data set to study the journey of more than 6,500 real-life psoriasis patients. As a result, SmartAnalyst’s customer, a pharmaceutical company, is changing the way it communicates with patients and doctors.
SmartAnalyst Inc. used the IBM Explorys clinical data set to boost physician adoption of certain cancer treatments
The IBM® Watson Health™ team helped SmartAnalyst use IBM Explorys® Offerings for Life Sciences to compare treatment patterns and time-to-event outcomes for almost 2,000 real world lines of therapy for multiple myeloma.
This webinar replay reviews how the IBM Global Business Services (GBS) team generated actionable insights by applying machine learning on integrated EHRs (IBM Explorys clinical data set) and has thus helped life science companies tailor their business strategies and achieve research breakthroughs.
Near-real time data access provides integrated views of the patient journey and clinical practice, enabling life sciences organizations to gain deep insights.
Heart attack and stroke are 2 of the top 10 causes of death worldwide. Identifying the proteins involved in each of them is the beginning of a journey to understanding how these diseases develop. In a novel experiment presented at the American Heart Association Scientific Sessions on November 12, 2017, and published in a supplement […]
In this brief, we share insights on challenges in managing outcomes-based contracts (OBCs) with health plans today and solutions to address these challenges, based on our conversations with more than a dozen life sciences companies.
In today’s healthcare system, we are not getting the value for the costs we are spending. It’s a complex issue with an equally complex set of potential solutions. But as the industry shifts to value-based care, we’ve reached a tipping point.